New two-amino acid insertion near codon 70 of the HIV type 1 protease gene

AIDS Research and Human Retroviruses

Volumn 21, Issue 4, 2005, Pages 311-313

  Winters, Mark A ^a,c   Kagan, Ron M ^b   Heseltine, Peter N R ^b   Merigan, Thomas C ^a  

^a STANFORD UNIVERSITY   (United States)

^b QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; ATAZANAVIR; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; PROTEINASE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; TENOFOVIR DISOPROXIL; VIRUS ENZYME;

AMINO ACID SEQUENCE; ARTICLE; CODON; DRUG SENSITIVITY; GENE INSERTION; GENE MUTATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TREATMENT FAILURE;

AMINO ACIDS; CODON; DRUG RESISTANCE, VIRAL; GENES, VIRAL; HIV INFECTIONS; HIV PROTEASE; HIV-1; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA;

EID: 18244384485     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2005.21.311     Document Type: Article

References (11)

1. Hirsch MS, Brun-Vezinet F, Clotet B, Conway B, Kuritzkes DR, D'Aquila RT, Demeter LM, Hammer SM, Johnson VA, Loveday C, Mellors JW, Jacobsen DM, and Richman DD: Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel. Clin Infect Dis 2003;37:113-128.
2. Panel on Clinical Practices for Treatment of HIV Infection: Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Available at URL http://www.aidsinfo.nih.gov/ guidelines/AA_102904.html (accessed February 2005).
3. Rhee SY, Gonzales MJ, Kantor R, Betts BJ, Ravela J, and Shafer RW: Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res 2003;31:298-303.
4. Winters MA, Coolley KL, Girard YA, Levee DJ, Hamdan H, Shafer RW, Katzenstein DA, and Merigan TC: A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors. J Clin Invest 1998;102:1769-1775.
5. 4 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitors. J Virol 2000;74:10707-10713.
6. Imamichi T, Murphy MA, Imamichi H, and Lane HC: Amino acid deletion at codon 67 and Thr-to-Gly change at codon 69 of human immunodeficiency virus type 1 reverse transcriptase confer novel drug resistance profiles. J Virol 2001;75:3988-3992.
7. de Jong JJ GJ, Lukashov VV, Hillebrand ME, Baan E, Huismans R, Danner SA, ten Veen JH, de Wolf F, and Jurriaans S: Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs. AIDS 1999;13:75-80.
8. Larder Ba BS, Kemp S. D., Hertogs K., Desmet R. L., Miller V., Sturmer M., Staszewski S, Ren J, Stammers DK, Stuart DI, and Pauwels R: A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance. Antimicrob Agents Chemother 1999;43:1961-1967.
9. Kim EY, Winters MA, Kagan RM, and Merigan TC: Functional correlates of insertion mutations in the protease gene of human immunodeficiency virus type 1 isolates from patients. J Virol 2001;75:11227-11233.
10. Sturmer M, Staszewski S, Doerr HW, and Hertogs K: A 6-base pair insertion in the protease gene of HIV type 1 detected in a protease inhibitor-naive patient is not associated with indinavir treatment failure. AIDS Res Hum Retroviruses 2003;19:967-968.
11. Grant RM KJ, Wrin T, Drews B, Javier J, Webb M, Petropolous CJ, and Hecht FM: HIV-1 with an insertion in the protease is drug-susceptible, replication-competent, and transmissible. Antivir Ther 2001;6:44.